A 52-year-old man comes with jaundice and extrapyramidal symptoms. On ophthalmic examination, the below finding is noted. The treatment is:
First, jaundice and extrapyramidal symptoms together make me think of Wilson's disease. Wilson's is a genetic disorder causing copper accumulation, leading to liver disease (jaundice) and neurological issues (extrapyramidal like tremors, dystonia). The ophthalmic sign would be Kayser-Fleischer rings, which are copper deposits in the cornea. The treatment for Wilson's is usually chelation therapy, like penicillamine or trientine, or zinc acetate to prevent copper absorption.
Looking at the options, the correct answer would be the chelating agent. If the options include penicillamine, that's the right choice. The other options might be other drugs not used for Wilson's, like antipsychotics for Parkinson's, which isn't the case here. Also, maybe a liver transplant if it's end-stage, but that's more for severe liver failure. But the presence of neurological symptoms points more to Wilson's needing chelation.
Wait, the extrapyramidal symptoms in Wilson's are due to copper toxicity in the basal ganglia. So the treatment must address copper overload. The options if they include penicillamine (a chelator) would be correct. Other options like antipsychotics (e.g., haloperidol) could worsen extrapyramidal symptoms. Or maybe something like levodopa, but that's for Parkinson's, which is different. Also, maybe a wrong option is a drug that's not a chelator.
The clinical pearl here is that Kayser-Fleischer rings and Wilson's disease are classic signs pointing to chelation therapy. Students should remember that Wilson's is an autosomal recessive disorder with ATP7B gene mutation, leading to copper accumulation. The treatment is lifelong, and early diagnosis is crucial to prevent neurological damage.
So, putting it all together, the correct answer is likely the chelating agent penicillamine. The other options would be incorrect because they don't address copper toxicity. The clinical pearl is the association of Kayser-Fleischer rings with Wilson's disease and the treatment with chelators.
**Core Concept**
This clinical scenario involves Wilson’s disease, an autosomal recessive disorder of copper metabolism characterized by hepatic dysfunction (jaundice) and neurologic symptoms (extrapyramidal signs). The key diagnostic clue is the presence of Kayser-Fleischer rings (copper deposits in the cornea). Treatment focuses on reducing copper levels via chelation or zinc therapy.
**Why the Correct Answer is Right**
The correct treatment for Wilson’s disease is **penicillamine** (or trientine), a chelating agent that binds copper and promotes its excretion. Zinc acetate is an alternative that inhibits intestinal copper absorption. These therapies target the underlying pathophysiology of copper overload, which causes oxidative stress and damage to the liver, basal ganglia, and cornea.
**Why Each Wrong Option is Incorrect**
**Option A:** Antipsychotics like haloperidol worsen extrapyramidal symptoms and are